Last reviewed · How we verify

NCT02541539

Effects of Lactobacillus Casei on Respiratory and Gastrointestinal Diseases in Adults

Completed NA Last updated 6 November 2017
What this trial tests

NA trial testing Lactobacillus casei Zhang in Healthy Volunteers in 150 participants. Completed in 30 September 2016.

Timeline
1 October 2015
Primary endpoint
30 September 2016
30 September 2016

Quick facts

Lead sponsorUniversiti Sains Malaysia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment150
Start date1 October 2015
Primary completion30 September 2016
Estimated completion30 September 2016
Sites1 location across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

Universiti Sains Malaysia — full company profile →

Who can join

Adults 18 to 81, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims to study the benefits of probiotics namely Lactobacillus casei Zhang (LCZ) in prevention of upper respiratory and gastrointestinal illnesses, which are found common among adults in Malaysia aged from 18 to 81 years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy Volunteers

Currently open trials in the same condition.

Other Universiti Sains Malaysia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02541539.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing